You Are Here: Home > About Arthritis > Arthritis in the News

News

Filters
Filters Apply Filters Clear All
 
Filters Applied: National
supplement news article

Jan 31

Sensors set stage for happier patients post-op
By combining wearable sensors with machine learning, Western Medical Biophysics and Surgery professor Matthew Teeter is helping patients with arthritis better understand their present conditions in order to have realistic expectations for life after surgery. Teeter was recently honoured by the...
Public
supplement news article

Jan 27

Arthritis Society Welcomes new President and CEO
Health and Senior Living Executive Trish Barbato Brings Focus on InnovationTORONTO – The Arthritis Society today announced the appointment of a new President and CEO to lead the organization into a new decade and further strengthen its efforts to support the six million Canadians living...
Arthritis Society Canada
supplement news article

Dec 18

New research takes aim at back pain in arthritis
One of 14 new awards announced by the Arthritis Society, brings annual research commitment to nearly $4 millionDecember 18, 2019 – TORONTO – Back pain. It’s the #1 cause of disability worldwide, so odds are you’ve probably experienced it. If you’re lucky, it went...
Arthritis Society Canada
supplement news article

Dec 12

Alberta will force patients to switch from biologics to cheaper biosimilar medications
Globe and Mail coverage of the Alberta biosimilars announcement, highlighting some (non-arthritis) patient groups' concerns.
The Globe and Mail
supplement news article

Dec 12

Biosimilar drugs to provide safe, effective treatment
The Alberta Government is changing coverage for biologics under the Alberta Drug Benefit List (ABDL). Public coverage for patients currently on certain originator biologics will be transitioned to biosimilars. This affects both patients who are new to biologics, and patients already receiving...
Public
supplement news article

Dec 11

Innovative Medicines Canada bans members from paying doctors fees for IV infusions
Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous infusions of their medications under a revised ethical code written by the industry group for brand-name drug makers. The goal is to remove incentives that encourage doctors to prescribe...
The Globe and Mail
supplement news article

Nov 27

Arthritis Society Recognized Among Canada’s Most Admired Corporate CulturesTM Trade
Investments in Research and Innovative Programming Transform Health CharityTORONTO – The Arthritis Society was today recognized among Canada’s Most Admired Corporate Cultures™  by Waterstone Human Capital. Each year Waterstone surveys thousands of organizations...
Arthritis Society Canada
supplement news article

Nov 22

A look at medical cannabis coverage’s growing pains
After the Arthritis Society’s extensive advocacy for medical cannabis research, it seemed only natural for the organization to cover the drug under its employee benefits plan. Features an interview with our COO, Cheryl McClellan, talking about our employee benefits solution.
Public
supplement news article

Nov 08

Being a mom with chronic pain wasn't part of the plan
Tara Mandarano's moving essay explores being a parent living with chronic pain from fibromyalgia, and its impact on her relatinoship with her 5-year-old daughter. 
Public
 |<  <  14 - 15 - 16 - 17 - 18 - 19 - 20 - 21 - 22 - 23  >  >| 
Load More